ES2103691B1 - Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales. - Google Patents

Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.

Info

Publication number
ES2103691B1
ES2103691B1 ES9600614A ES9600614A ES2103691B1 ES 2103691 B1 ES2103691 B1 ES 2103691B1 ES 9600614 A ES9600614 A ES 9600614A ES 9600614 A ES9600614 A ES 9600614A ES 2103691 B1 ES2103691 B1 ES 2103691B1
Authority
ES
Spain
Prior art keywords
extract
papilomas
warts
euphorbia
mycosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9600614A
Other languages
English (en)
Other versions
ES2103691A1 (es
Inventor
Mazario Adolfo Garijo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9600614A priority Critical patent/ES2103691B1/es
Priority to PCT/ES1997/000058 priority patent/WO1997033598A1/es
Priority to AU19276/97A priority patent/AU1927697A/en
Publication of ES2103691A1 publication Critical patent/ES2103691A1/es
Application granted granted Critical
Publication of ES2103691B1 publication Critical patent/ES2103691B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

USO DEL EXTRATO DE EUPHORBIA CHARACIAS PARA LA FABRICACION DE UN MEDICAMENTO UTIL PARA EL TRATAMIENTO Y PREVENCION DE PAPILOMAS, VERRUGAS Y MICOSIS, EN HUMANOS Y ANIMALES. SE TRATA DE UNA NUEVA APLICACION EN MEDICINA. LAS PROPIEDADES CURATIVAS Y PREVENTIVAS DEL EXTRACTO DE EUPHORBIA CHARACIAS FRENTE A TUMORES EPITELIALES, PAPILOMAS, VERRUGAS Y MICOSIS EXTERNAS. EL EXTRATO DE EUPHORBIA SE MUESTRA COMO UN ACTIVO REGENERADOR EPITELIAL, A LA VEZ QUE EVITA LA COLONIZACION DE LA PIEL POR HUESPEDES EXTRAÑOS. LA APLICACION SE HACE EN FORMA EXTERNA. EL EXTRACTO, DILUIDO Y REBAJADO, ES UN PODEROSO ANTIMICOTICO. EFICAZ PARA TRATAR, DESDE UNA PTIRIASIS VERSICOLOR, HASTA EL PIE DE ATLETA. EN PLAZOS MUY INFERIORES A LOS DE LOS TRATAMIENTOS AHORA EMPLEADOS. A MAYOR DILUCION DEL LATEX, SIRVE DE PREVENTIVO, SOBRE TODO EN EL PIE, PARA HONGOS, VERRUGAS Y PAPILOMAS.
ES9600614A 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales. Expired - Fee Related ES2103691B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9600614A ES2103691B1 (es) 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.
PCT/ES1997/000058 WO1997033598A1 (es) 1996-03-14 1997-03-11 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales
AU19276/97A AU1927697A (en) 1996-03-14 1997-03-11 Use of euphorbia characias extract for the fabrication of a medicament useful for the prevention and treatment of papillomas, warts and mycosis in humans and animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9600614A ES2103691B1 (es) 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.

Publications (2)

Publication Number Publication Date
ES2103691A1 ES2103691A1 (es) 1997-09-16
ES2103691B1 true ES2103691B1 (es) 1998-04-16

Family

ID=8294167

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9600614A Expired - Fee Related ES2103691B1 (es) 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.

Country Status (3)

Country Link
AU (1) AU1927697A (es)
ES (1) ES2103691B1 (es)
WO (1) WO1997033598A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342071A1 (fr) * 1975-10-16 1977-09-23 Ohf Etudes Participations Produit antiverruqueux et coricide
DE3705151A1 (de) * 1987-02-18 1988-09-01 Brigitte Luenemann Warzenmittel
DE3805965A1 (de) * 1988-02-25 1989-09-07 Tamas Geb Szenasi Eszter Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe

Also Published As

Publication number Publication date
ES2103691A1 (es) 1997-09-16
WO1997033598A1 (es) 1997-09-18
AU1927697A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
Draelos The ability of onion extract gel to improve the cosmetic appearance of postsurgical scars
Riyaz et al. Leprosy: Trophic skin ulcers
Flint et al. Nail and skin disorders of the foot
US20060241729A1 (en) Method of treating nail fungus onychomycosis
Taylor et al. Postprocedural wound-healing efficacy following removal of dermatosis papulosa nigra lesions in an African American population: a comparison of a skin protectant ointment and a topical antibiotic
AR119031A1 (es) Formulaciones farmacéuticas antibacterianas de amplio espectro que comprenden lisozima y métodos de utilización de la misma
Hilerowicz et al. Thermomechanical ablation‐assisted photodynamic therapy for the treatment of acne vulgaris. A retrospective chart review of 30 patients
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
AR045865A1 (es) El uso de un polifenol para el tratamiento de una lesion cancerosa o pre-cancerosa de la piel
Sander et al. Advancement flap as a novel treatment for a pododermatitis lesion in a red-tailed hawk (Buteo jamaicensis)
Gupta et al. Treating ingrown toenails by nail splinting with a flexible tube: an Indian experience
Park et al. Treatment of ingrown nail with a special device composed of shape‐memory alloy
ES2103691B1 (es) Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.
Gualdi et al. Surgical treatment of ingrown toe nail: the Monaldi technique, a new simple proposal
ES2221373T3 (es) Procedimiento para el tratamiento del dolor asociado a neuromas.
Longhurst et al. Dry heel fissures: Treatment and prevention
MOHAMED et al. Comparison of analgesic effect of perineural dextrose injection and low level laser therapy for osteoarthritis knee pain
Akarsu et al. Cryotherapy for common premalignant and malignant skin disorders
Dziewulski et al. Acute management of facial burns
CY1112428T1 (el) Θεραπειες για ασθενειες του κερατοειδους
KR101913564B1 (ko) 무좀치료 연고조성물
ES2105643T3 (es) Uso de la 2-(4-(4-clorofenil)ciclohexil)-3-hidroxi-1,4-naftoquinona para el tratamiento del cancer.
Arafat Abdel-Maksoud Nail-fold excision without matricectomy for treatment of ingrown toe nails
CO2022016153A2 (es) Inhibidores de il4i1 y métodos de uso
Sahibole et al. Diabetic foot ulcers treated with unani formulation: A case series

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970916

Kind code of ref document: A1

Effective date: 19970916

FD2A Announcement of lapse in spain

Effective date: 20180807